Pre-exposure prophylaxis prescribing and retention in care among heterosexual women at a community-based comprehensive sexual health clinic
| Autor: | Uriel R. Felsen, Connie Park, Sachin Jain, Oni J. Blackstock, Viraj V. Patel |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Adult
Male Safe Sex 0301 basic medicine medicine.medical_specialty Health (social science) Sexual health clinic Social Psychology Anti-HIV Agents Human immunodeficiency virus (HIV) Black People HIV Infections Hiv testing medicine.disease_cause Article Young Adult 03 medical and health sciences Pre-exposure prophylaxis 0302 clinical medicine Nursing Health care medicine Humans 030212 general & internal medicine Medical prescription Heterosexuality Community based business.industry Public Health Environmental and Occupational Health Hispanic or Latino Middle Aged Patient Acceptance of Health Care medicine.disease Retention in care 030112 virology Black or African American Sexual Partners Family medicine Female Pre-Exposure Prophylaxis business |
| Zdroj: | AIDS Care. 29:866-869 |
| ISSN: | 1360-0451 0954-0121 |
| Popis: | In the United States, heterosexual women account for 20% of new HIV infections. As a user-controlled HIV prevention method, pre-exposure prophylaxis (PrEP) has substantial potential to reduce new infections among women. However, among women, PrEP is vastly underutilized. To guide efforts to increase women-at-risk's PrEP use, we sought to describe the characteristics of women prescribed PrEP as well as their retention in PrEP care. We conducted a chart review of women who received care at a comprehensive sexual health clinic within a large urban health care system. Referral sources included the health care system's clinics and HIV testing program, as well as local community-based organizations. From 1 December 2014 to 5 August 2016, 554 women received care at the clinic. During this period, 21 heterosexual women (3.8%) received at least one prescription for daily oral PrEP. For women prescribed PrEP, median age was 35 years old (range: 20-52). The majority (66.7%) were either Latina or non-Latina Black and most (81.2%) had public health insurance. The most common PrEP indication was being in a known sero-discordant partnership (85.7%). Of women in such partnerships, 83.3% reported their male partner was currently taking antiretroviral medications (ARVs) and 16.7% reported trying to conceive with their partner (not mutually exclusive). Of women with ARV-using partners, 66.7% reported that their partners were virally suppressed. Retention in PrEP care at three months was 61.1% and, at six months, 37.5%. Further study is necessary to expand PrEP to women whose risk factors extend beyond being in a known sero-discordant partnership, and to understand the reasons for the observed drop-off in PrEP care visits in real-world settings. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |